LR-1

N/A

Report date: 2023/12/29 16:53:20
First In Class

Base Information

Drug NameLR-1
Drug Alias NameLR1LR-1
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interference
TargetsNot applicable
Therapy Area/IndicationsLiver CirrhosisLiver FailureLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLerna Biopharma Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLerna Biopharma Pte Ltd
Inactive CompaniesN/A
Active IndicationsLiver CirrhosisLiver FailureLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A